Search Results - "Tuljak, Aneja"

Non-clinical evaluation of pmIL12 gene therapy for approval of the phase I clinical study by Markelc, Bostjan, Jesenko, Tanja, Kranjc Brezar, Simona, Omerzel, Masa, Lampreht Tratar, Ursa, Rencelj, Andrej, Matkovic, Urska, Znidar, Katarina, Kos, Spela, Levpuscek, Kristina, Pisljar, Ziva, Kesar, Ursa, Komel, Tilen, Bozic, Tim, Tuljak, Aneja, Hudej, Rosana, Peterka, Matjaz, Kamensek, Urska, Cör, Andrej, Gasljevic, Gorana, Nemec Svete, Alenka, Tozon, Natasa, Sersa, Gregor, Cemazar, Maja

“…Immunotherapeutic drugs are promising medicines for cancer treatment. A potential candidate for immunotherapy is interleukin-12 (IL-12), a cytokine well known…”
Get full text

Non-Clinical In Vitro Evaluation of Antibiotic Resistance Gene-Free Plasmids Encoding Human or Murine IL-12 Intended for First-in-Human Clinical Study by Kos, Spela, Bosnjak, Masa, Jesenko, Tanja, Markelc, Bostjan, Kamensek, Urska, Znidar, Katarina, Matkovic, Urska, Rencelj, Andrej, Sersa, Gregor, Hudej, Rosana, Tuljak, Aneja, Peterka, Matjaz, Cemazar, Maja

“…Interleukin 12 (IL-12) is a key cytokine that mediates antitumor activity of immune cells. To fulfill its clinical potential, the development is focused on…”
Get full text